Volume 129, Issue 6, 2022-6-1, Pages A3-e68

Articles in this issue:

1. Editorial Board

2. Contents

3. This Issue at a Glance

4. A Simple Vista en Este Número

5. 期刊一览

6. Abstracts

7. ROI, COI, and the Ethical Obligations of Journals

8. Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema

9. Results of the United States Food and Drug Administration Clinical Trial of the CustomFlex Artificial Iris

10. Corneal Keloid in Lowe Syndrome

11. Genome-Wide Association Study Identifies Two Common Loci Associated with Pigment Dispersion Syndrome/Pigmentary Glaucoma and Implicates Myopia in its Development

12. Alcohol, Intraocular Pressure, and Open-Angle Glaucoma

13. Functional Amblyopia in Segmental Optic Nerve Hypoplasia

14. Cuticular Drusen in Age-Related Macular Degeneration

15. Spontaneous Regression of Presumed Iris Melanocytoma

16. Outcomes of Uveitic Macular Edema in the First-line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial

17. An Unusual Cause of Choroidal Excavation

18. Visual Field Loss Impacts Vision-Specific Quality of Life by Race and Ethnicity

19. Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients

20. Photoreceptor Layer Thinning Is an Early Biomarker for Age-Related Macular Degeneration

21. Genotypic and Phenotypic Spectrum of Foveal Hypoplasia

22. Ultrawide-field OCT for Retinoblastoma

23. The Pandemic Is Not Associated with Endophthalmitis Decrease after Anti–Vascular Endothelial Growth Factor Injections

24. Time to Uveitis Control with Methotrexate and Mycophenolate Mofetil

25. Re: Chiang et al.: International Classification of Retinopathy of Prematurity: Third Edition ( Ophthalmology. 2021;128:e51–e68)

26. Reply

27. Re: Le et al.: Associations between age-related eye diseases and Charles Bonnet Syndrome in participants of the Age-Related Eye Disease Study 2: Report Number 26 ( Ophthalmology. 2022;129:233–235)

28. Reply